Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Effexor metabolite in Phase III testing

Posted by jrbecker on July 10, 2003, at 12:57:18

It looks like some pharm company is trying to bring a new drug containing an active metabolite of Effexor to the market. Currently being called DVS-233 SR, it is in Phase III for depression.

I'm not sure if this is Wyeth (Effexor's manuf.) or another company that's testing the drug. It could be one way Wyeth's plans to extend its share of the market once Effexor goes generic in 2007 (a la Lexapro succeeding Celexa, Focalin succeeding Ritalin). Or maybe Wyeth is leasing the metabolite out to another pharm company.

Supposedly, anybody that has taken Effexor within 90 days is excluded from the study. Whether you have and you decide to share that information with them, well, that's up to you.

Go to and search by "DVS-233 " if you would like to participate, to see if there is a test site near you.

The locations I was able to find were: Santa Monica, CA; Newport Beach, CA; Orange, CA; Wheat Ridge, CO; New Britain, CT; Winter Park, FL; St. Petersburg, FL; Chicago, IL; Okemos, MI; Omaha, NE; Moorestown, NJ; New York, NY; Havertown, PA; Dallas, TX; Austin, TX; Washington, DC




Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:jrbecker thread:240601